CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) may be able to join ...
Phase 1
Atlanta, Georgia, United States and 20 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Atlanta, Georgia, United States and 71 other locations
This phase II trial studies the effect of acalabrutinib and obinutuzumab in treating patients with follicular lymphoma or other indolent non...
Phase 2
Atlanta, Georgia, United States
A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas....
Phase 2
Newnan, Georgia, United States and 3 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Atlanta, Georgia, United States and 71 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Atlanta, Georgia, United States and 59 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Atlanta, Georgia, United States and 41 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Lawrenceville, Georgia, United States and 215 other locations
with obinutuzumab in treating patients with B-cell non-Hodgkin lymphoma that has returned after a period of improvement or not responding to...
Phase 1
Atlanta, Georgia, United States and 1 other location
how well they work in treating patients with non-Hodgkin or Hodgkin lymphoma that has come back and does not respond to treatment. Monoclona...
Phase 1, Phase 2
Atlanta, Georgia, United States and 1 other location
Clinical trials
Research sites
Resources
Legal